NCT07119892 (Lifestyle Inte) is a NA clinical trial of Lifestyle Modification (Exercise + Diet) in Type 2 Diabetes Mellitus, sponsored by Sinai University.

Who is sponsoring NCT07119892?

NCT07119892 is sponsored by Sinai University.

What drugs are being tested in NCT07119892?

Interventions in NCT07119892: Lifestyle Modification (Exercise + Diet).

What condition does NCT07119892 study?

NCT07119892 studies Type 2 Diabetes Mellitus, Inflammation, Chronic Low-Grade, Chronic Kidney Disease, Stage 3 Chronic Kidney Disease, Stage 4 Chronic Kidney Disease.

Is NCT07119892 still recruiting?

NCT07119892 is currently completed. Last updated 17 August 2025.

Last reviewed 2025-08-17 · How we verify

NCT07119892: Lifestyle Inte

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lifestyle Intervention and Its Effects on Inflammatory Cytokines and Oxidative Stress Markers in Diabetic Chronic Kidney Disease Patients: A Randomized Controlled Trial

Completed NA Last updated 17 August 2025

What this trial tests

NA trial testing Lifestyle Modification (Exercise + Diet) in Type 2 Diabetes Mellitus in 60 participants. Completed in 25 June 2025.

Timeline

1 March 2025

Primary endpoint
25 June 2025

25 June 2025

Quick facts

Lead sponsor	Sinai University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	1 March 2025
Primary completion	25 June 2025
Estimated completion	25 June 2025
Sites	1 location across Egypt

Drugs / interventions tested

Lifestyle Modification (Exercise + Diet)

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Inflammation, Chronic Low-Grade — all drugs for Inflammation, Chronic Low-Grade →
Chronic Kidney Disease — all drugs for Chronic Kidney Disease →
Stage 3 Chronic Kidney Disease — all drugs for Stage 3 Chronic Kidney Disease →

Sponsor

Sinai University

Who can join

Adults 36 to 58, any sex, with Type 2 Diabetes Mellitus or Inflammation, Chronic Low-Grade. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial investigated the effects of a 12-week structured lifestyle intervention-including supervised aerobic exercise and a calorie-restricted diet-on inflammatory cytokines and oxidative stress biomarkers in overweight adults with type 2 diabetes mellitus (T2DM) and moderate chronic kidney disease (CKD stages 3-4). A total of 60 sedentary participants aged 36-58 years were randomly assigned to either the intervention group or the control group. The primary outcomes included changes in TNF-α, IL-6, and sCRP levels. Secondary outcomes assessed oxidative stress markers (MDA, CD) and antioxidant enzymes (GSH, SOD, GPx).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Sinai University trials

Trials by the same sponsor.

NCT07366476 — Effectiveness of Electrical Stimulation and Biofeedback on Fecal Incontinence in Children With Repaired Anorectal Malfor · NA · recruiting
NCT07247305 — Screen Culture's Impact on Generation Z Adolescents' Physical Activity, Posture and Well-being in Egypt · not yet recruiting
NCT07170397 — Effects of Laser Acupuncture Treatment in Hypertension Haemodialysis Patients · NA · not yet recruiting
NCT07099482 — "Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds" · NA · not yet recruiting
NCT07151300 — Phonophoresis With Bee Venom: Evaluating Its Efficacy in Managing Pain and Enhancing Mobility in Knee Osteoarthritis Pat · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07119892 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sinai University
Last refreshed: 17 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07119892.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing